Brief: Sinopharm Group Posts Qtrly Total Operating Revenue RMB 140.77 Billion
April 27 (Reuters) - Sinopharm Group Co Ltd 1099.HK: SINOPHARM GROUP: QTRLY TOTAL OPERATING REVENUE RMB 140.77 BILLION SINOPHARM GROUP - QTRLY NET PROFIT ATTRIBUTABLE RMB1.41 BILLION Source text: ID:nHKS3Zv82 Further company coverage: 1099.HK
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For